Biktarvy and Panic attacks - a phase IV clinical study of FDA data

Summary:

Panic attacks is reported as a side effect among people who take Biktarvy (bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate), especially for people who are male, 50-59 old, also take Atripla, and have Bone pain.

The phase IV clinical study analyzes which people have Panic attacks when taking Biktarvy. It is created by eHealthMe based on reports of 19,474 people who have side effects when taking Biktarvy from the FDA, and is updated regularly.

What is Biktarvy?

Biktarvy has active ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 19,541 Biktarvy users. Check the latest studies of Biktarvy.

What is Panic attacks?

Panic attacks is found to be associated with 2,582 drugs and 2,067 conditions by eHealthMe. Check the latest studies of Panic attacks.

On Dec, 15, 2025

19,474 people reported to have side effects when taking Biktarvy.
Among them, 22 people (0.11%) have Panic attacks.

Among these 22 people:

What is the gender of people who have Panic attacks when taking Biktarvy? *

female: 27.27 %
male: 72.73 %

What is the age of people who have Panic attacks when taking Biktarvy? *

What are other drugs people take besides Biktarvy? *

What are other side effects people have besides Panic attacks? *

Stress And Anxiety: 14 people, 63.64%
Depression: 11 people, 50.00%
Emotional Distress: 11 people, 50.00%
Pain: 11 people, 50.00%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 10 people, 45.45%
Osteopenia (a condition where bone mineral density is lower than normal): 5 people, 22.73%
Osteoporosis (bones weak and more likely to break): 5 people, 22.73%
Bone Density Decreased: 5 people, 22.73%
Gait Disturbance: 4 people, 18.18%
Dyspnea (difficult or laboured breathing): 4 people, 18.18%

What are the existing conditions these people have? *

Weakness: 3 people, 13.64%
Sensation Of Blood Flow: 3 people, 13.64%
Osteoporosis (bones weak and more likely to break): 3 people, 13.64%
Irritable Bowel Syndrome: 3 people, 13.64%
Fatigue (feeling of tiredness): 3 people, 13.64%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 13.64%
Bone Pain: 3 people, 13.64%
Stress And Anxiety: 1 person, 4.55%
High Blood Cholesterol: 1 person, 4.55%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Biktarvy and have Panic attacks?

- Check whether Panic attacks is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Biktarvy:

Biktarvy (19,541 reports)

Panic attacks treatments and more:

Panic attacks (65,702 reports)

How severe was Panic attacks and when was it recovered:

Panic attacks in Biktarvy

Expand to all the drugs that have ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate:

Panic attacks and drugs with ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Biktarvy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attacks:

Panic attacks (2,582 drugs)

Browse all the conditions that are associated with Panic attacks:

Panic attacks (2,067 conditions)

Drugs similar to Biktarvy and Panic attacks :

How the study uses the data?

The study uses data from the FDA. It is based on bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Biktarvy) and Biktarvy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.